Top Market Insights Stories
Market Insights
What to expect from Big Pharma (and Biden's push to lower drug prices) in 2024
By Jeanna M. Wacker, Tasha Gerasimow and Nick JohnstonA look at new legal battles and drug regulations, including the administration's new initiatives to reduce drug costs and next steps in the FTC's attempt to address improperly listed patents in the FDA's Orange Book.
Market Insights










